Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients
出版年份 2016 全文链接
标题
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 6, Pages 1451-1465
出版商
Oxford University Press (OUP)
发表日期
2016-02-05
DOI
10.1093/jac/dkv494
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients
- (2015) Matthew J. Feinstein et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks
- (2015) Romina Quercia et al. CLINICAL DRUG INVESTIGATION
- Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-
- (2015) M Krikke et al. HIV MEDICINE
- The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients
- (2015) Wei Song et al. JOURNAL OF LIPID RESEARCH
- Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study
- (2015) Line D Rasmussen et al. Lancet HIV
- A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals
- (2015) Graeme J. Moyle et al. PLoS One
- 2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque
- (2014) Markella V. Zanni et al. AIDS
- Short Communication: Effects of Omega-3 Fatty Acids on Triglycerides and High-Density Lipoprotein Subprofiles in HIV-Infected Persons with Hypertriglyceridemia
- (2014) Anu Paranandi et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health
- (2014) Eduard J Beck et al. ANTIVIRAL THERAPY
- Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy
- (2014) A. R. Eckard et al. JOURNAL OF INFECTIOUS DISEASES
- Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial
- (2014) Jose R Arribas et al. LANCET INFECTIOUS DISEASES
- Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
- (2014) Patricia Echeverría et al. PLoS One
- Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway
- (2014) Grace M Egeland et al. European Journal of Preventive Cardiology
- Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants
- (2013) Frank J. Palella et al. AIDS
- Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey
- (2013) Nazisa Hejazi et al. BMC PUBLIC HEALTH
- SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
- (2013) R. Campo et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin
- (2013) Miao Hu et al. Expert Opinion on Drug Metabolism & Toxicology
- Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART
- (2013) José L. Casado et al. HIV CLINICAL TRIALS
- Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate–Based Single-Tablet Regimens
- (2013) Anthony M. Mills et al. HIV CLINICAL TRIALS
- Progression of Carotid Intima-Media Thickness and Coronary Artery Calcium Over 6 Years in an HIV-Infected Cohort
- (2013) Gretchen E. Volpe et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function
- (2013) Samir K. Gupta et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study
- (2013) P. Monteiro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial
- (2013) A. Bonjoch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy
- (2013) Claudio Ucciferri et al. JOURNAL OF MEDICAL VIROLOGY
- Intensive Lifestyle Modification Reduces Lp-PLA2 in Dyslipidemic HIV/HAART Patients
- (2013) JOSHUA S. WOOTEN et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes
- (2013) Beth S. Zha et al. PLoS One
- Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART
- (2013) Rosmeri K. Lazzaretti et al. TheScientificWorldJOURNAL
- Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy
- (2012) Lander Egaña-Gorroño et al. AIDS
- Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk
- (2012) Leonardo Calza et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The Effect of a 12-Week Course of Omega-3 Polyunsaturated Fatty Acids on Lipid Parameters in Hypertriglyceridemic Adult HIV-infected Patients Undergoing HAART: A Randomized, Placebo-Controlled Pilot Trial
- (2012) Barry S. Peters et al. CLINICAL THERAPEUTICS
- Effect of Darunavir on Lipid Profile in HIV-Infected Patients
- (2012) Edgar Turner Overton et al. HIV CLINICAL TRIALS
- Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors
- (2012) Leonardo Calza et al. HIV CLINICAL TRIALS
- Coronary artery disease and HIV; getting to the HAART of the matter
- (2012) Chrysostomos A. Mavroudis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients
- (2011) SME Vrouenraets et al. HIV MEDICINE
- Combination of Niacin and Fenofibrate with Lifestyle Changes Improves Dyslipidemia and Hypoadiponectinemia in HIV Patients on Antiretroviral Therapy: Results of “Heart Positive,” a Randomized, Controlled Trial
- (2011) Ashok Balasubramanyam et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia
- (2011) Ching-Lan Lu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
- (2010) Esteban Martinez et al. AIDS
- Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population
- (2010) Sylvie Lang et al. AIDS
- A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine
- (2010) Laura Waters et al. AIDS
- Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men
- (2010) Paul A Randell et al. ANTIVIRAL THERAPY
- Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected PatientsA Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4Antiretroviral Drugs, Risk of MI, and HIV
- (2010) Sylvie Lang ARCHIVES OF INTERNAL MEDICINE
- Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
- (2010) Nina Friis-Møller et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients
- (2009) Dominic Chow et al. AIDS
- Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients
- (2009) Takara L Stanley et al. AIDS
- Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
- (2009) Priscilla Y Hsue et al. AIDS
- Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial
- (2009) Elisabeth Aslangul et al. AIDS
- HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies
- (2009) E Hulten et al. HEART
- Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection
- (2009) L Calza et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir
- (2009) Michael Sension et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen
- (2009) M. Gerschenson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
- (2009) Signe Westring Worm et al. JOURNAL OF INFECTIOUS DISEASES
- Development of Appropriate Coronary Heart Disease Risk Prediction Models in HIV-Infected Patients
- (2008) Morris Schambelan et al. CIRCULATION
- Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy
- (2008) Judith S. Currier et al. CIRCULATION
- Ezetimibe Alone Reduces Low‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy
- (2008) David A. Wohl et al. CLINICAL INFECTIOUS DISEASES
- Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors
- (2008) Leonardo Calza et al. CURRENT HIV RESEARCH
- European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
- (2008) JD Lundgren et al. HIV MEDICINE
- Safety and Efficacy of Simvastatin for the Treatment of Dyslipidemia in Human Immunodeficiency Virus–Infected Patients Receiving Efavirenz-Based Highly Active Antiretroviral Therapy
- (2008) Anita P Rahman et al. PHARMACOTHERAPY
- Lipid-Lowering Efficacy and Safety After Switching to Atazanavir-Ritonavir–Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus
- (2008) Sean T Nguyen et al. PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More